Arquivamento definitivo - Art. 33 da LPI
#11.1.1
07/16/2019
RPI 2532
Application data
Number
112017022296Type
Filing
Publication
PCT
US2016028179 The application was abandoned: examination was not requested within the 36 months following the 04/18/2016 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 07/16/2019. We update with every new RPI gazette, published weekly.
Applicants
BOSTON BIOMEDICAL, INC.
US
Inventors
C. L. (pessoa física)
US
D. L. (pessoa física)
US
D. K. (pessoa física)
US
L. B. (pessoa física)
US
Y. L. (pessoa física)
US
Y. G. (pessoa física)
US
IPC Classification
Priority claims
US
62/149,349 · 04/17/2015
Abstract
Métodos compreendendo administração e kits compreendendo pelo menos um composto de fórmula (I); e pelo menos uma terapia anticâncer adicional escolhida de panitumumabe, cetuximabe, capecitabina, CAPOX, regorafenib e FOLFOX.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
07/16/2019
RPI 2532
#11.1
05/07/2019
RPI 2522
#1.3
07/10/2018
RPI 2479
#1.1
10/24/2017
RPI 2442
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.